Myron Holubiak
2022
In 2022, Myron Holubiak earned a total compensation of $1.2M as Executive Vice Chairman at Citius Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $170,000 |
---|---|
Option Awards | $620,056 |
Salary | $450,000 |
Total | $1,240,056 |
Holubiak received $620.1K in option awards, accounting for 50% of the total pay in 2022.
Holubiak also received $170K in non-equity incentive plan and $450K in salary.
Rankings
In 2022, Myron Holubiak's compensation ranked 2,614th out of 5,753 executives tracked by ExecPay. In other words, Holubiak earned more than 54.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,614 | 55th |
Manufacturing | 1,454 | 54th |
Chemicals And Allied Products | 661 | 53rd |
Drugs | 614 | 54th |
Pharmaceutical Preparations | 441 | 54th |
Holubiak's colleagues
We found three more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2022.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018